Pan-pan Qiu , Shi-jie Cai , Li-li Guo , Wei Hu , Hong-yan Song , Tai-hong Huang , Zhi-ye Xu , Sen Wang
{"title":"Elevated CD4− CD8− double-negative T cells in the peripheral blood of SFTS patients are associated with disease severity","authors":"Pan-pan Qiu , Shi-jie Cai , Li-li Guo , Wei Hu , Hong-yan Song , Tai-hong Huang , Zhi-ye Xu , Sen Wang","doi":"10.1016/j.cca.2025.120312","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Severe fever with thrombocytopenia syndrome (SFTS), caused by the Dabie bandavirus, is a fatal infectious disease with no specific vaccines or antiviral treatments. Early diagnosis and severity assessment are critical for clinical management.</div></div><div><h3>Methods</h3><div>This study analyzed peripheral blood samples from 81 SFTS patients and healthy controls, focusing on the distribution of CD4<sup>+</sup>, CD8<sup>+</sup>, CD4<sup>+</sup>CD8<sup>+</sup> double-positive T (DPT) cells, and CD4<sup>−</sup>CD8<sup>−</sup> double-negative T (DNT) cells. The relationship between T cell subsets, clinical parameters, viral load, and cytokine levels was examined for diagnostic and prognostic potential.</div></div><div><h3>Results</h3><div>DPT cells were lower and DNT cells higher in SFTS patients compared to controls. DNT cell proportions were higher in severe and fatal cases, correlating positively with viral load, APTT, TT, D-dimer, ferritin, and LDH, and negatively with platelet count, HDL, and fibrinogen. DNT cells were also positively correlated with IFN-α and IFN-γ levels, and higher in patients with complications like shock and sepsis. Furthermore, Cox regression analysis revealed that an elevated DNT cell proportion was an independent risk factor for poor prognosis in SFTS patients.</div></div><div><h3>Conclusion</h3><div>DNT cell proportion changes are linked to SFTS severity and prognosis, suggesting DNT cells as potential biomarkers for early diagnosis and prognosis assessment.</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"574 ","pages":"Article 120312"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898125001913","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Severe fever with thrombocytopenia syndrome (SFTS), caused by the Dabie bandavirus, is a fatal infectious disease with no specific vaccines or antiviral treatments. Early diagnosis and severity assessment are critical for clinical management.
Methods
This study analyzed peripheral blood samples from 81 SFTS patients and healthy controls, focusing on the distribution of CD4+, CD8+, CD4+CD8+ double-positive T (DPT) cells, and CD4−CD8− double-negative T (DNT) cells. The relationship between T cell subsets, clinical parameters, viral load, and cytokine levels was examined for diagnostic and prognostic potential.
Results
DPT cells were lower and DNT cells higher in SFTS patients compared to controls. DNT cell proportions were higher in severe and fatal cases, correlating positively with viral load, APTT, TT, D-dimer, ferritin, and LDH, and negatively with platelet count, HDL, and fibrinogen. DNT cells were also positively correlated with IFN-α and IFN-γ levels, and higher in patients with complications like shock and sepsis. Furthermore, Cox regression analysis revealed that an elevated DNT cell proportion was an independent risk factor for poor prognosis in SFTS patients.
Conclusion
DNT cell proportion changes are linked to SFTS severity and prognosis, suggesting DNT cells as potential biomarkers for early diagnosis and prognosis assessment.
期刊介绍:
The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.
The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.